NCT05627323 2026-01-29CAR T Cells in Patients With MMP2+ Recurrent or Progressive GlioblastomaChimeric TherapeuticsPhase 1 Active not recruiting42 enrolled
NCT04214392 2025-10-06Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive GlioblastomaCity of Hope Medical CenterPhase 1 Active not recruiting19 enrolled